VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Recent advances in feature selection methods for breast cancer recurrence prediction: A systematic review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...
Under real-world haze conditions, the captured images not only suffer from the haze but also are affected by the noise, which significantly deteriorates the visibility of images. However, most of ...